MINDBODY (NASDAQ:MB)‘s stock had its “buy” rating reaffirmed by Craig Hallum in a research note issued on Thursday, The Fly reports. They presently have a $40.00 target price on the technology company’s stock, up from their previous target price of $32.00. Craig Hallum’s target price would suggest a potential upside of 19.94% from the stock’s previous close.
MB has been the subject of several other research reports. Morgan Stanley upped their price target on shares of MINDBODY from $34.00 to $37.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 30th. BidaskClub upgraded shares of MINDBODY from a “hold” rating to a “buy” rating in a research report on Wednesday, January 24th. KeyCorp restated a “buy” rating and issued a $41.00 price target (up previously from $34.00) on shares of MINDBODY in a research report on Monday, January 22nd. Zacks Investment Research downgraded shares of MINDBODY from a “buy” rating to a “hold” rating in a research report on Wednesday, November 1st. Finally, UBS Group restated a “buy” rating and issued a $40.00 price target (up previously from $34.00) on shares of MINDBODY in a research report on Thursday, November 9th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $35.23.
Shares of MINDBODY (NASDAQ:MB) opened at $33.35 on Thursday. The firm has a market cap of $1,562.11, a P/E ratio of -87.76 and a beta of -0.08. MINDBODY has a 1-year low of $21.57 and a 1-year high of $36.25. The company has a current ratio of 9.20, a quick ratio of 9.20 and a debt-to-equity ratio of 0.06.
In other MINDBODY news, CEO Richard Lee Stollmeyer sold 17,741 shares of the stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $30.30, for a total value of $537,552.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Luxor Capital Group, Lp bought 43,000 shares of the business’s stock in a transaction on Monday, February 12th. The stock was bought at an average price of $31.36 per share, with a total value of $1,348,480.00. The disclosure for this purchase can be found here. In the last quarter, insiders sold 92,348 shares of company stock valued at $2,883,809. Insiders own 8.22% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the business. Gotham Asset Management LLC bought a new position in shares of MINDBODY during the 4th quarter valued at $253,000. ClariVest Asset Management LLC bought a new position in shares of MINDBODY during the 3rd quarter valued at $269,000. Nordea Investment Management AB bought a new position in shares of MINDBODY during the 3rd quarter valued at $269,000. UBS Asset Management Americas Inc. bought a new position in shares of MINDBODY during the 4th quarter valued at $271,000. Finally, Arthur M. Cohen & Associates LLC bought a new position in shares of MINDBODY during the 4th quarter valued at $274,000. Institutional investors own 87.69% of the company’s stock.
WARNING: This piece was originally reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece can be viewed at https://www.com-unik.info/2018/02/22/mindbody-mb-earns-buy-rating-from-craig-hallum.html.
MINDBODY Company Profile
MINDBODY, Inc is a provider of cloud-based business management software for the wellness services industry and operates as a consumer marketplace with local business subscribers on its platform. The Company’s subscribers provide a range of wellness services to active consumers. Its integrated software and payments platform helps business owners in the wellness services industry run, market and build their businesses.
Receive News & Ratings for MINDBODY Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY and related companies with MarketBeat.com's FREE daily email newsletter.